Medexus gets Health Canada nod to market tumor imaging material Gleolan for neurosurgery

Al's Comment:

 Gleolan is finally approved in Canada.   It has been standard of care in Europe for many years before it was approved in the USA 3 years ago.   According to the article cited , it doubles the chance of a complete resection, and doubles the 6 month progression free survival rate.  This is a dye used at the time of surgery to make it easier for the surgeon to identify where the tumor is.


Posted on: 09/11/2020

Medexus gets Health Canada nod to market tumor imaging material Gleolan for neurosurgery

 


Click HERE to return to brain tumor news headlines.